-
Je něco špatně v tomto záznamu ?
Antiviral effect of HPMPC (Cidofovir®), entrapped in cationic liposomes: in vitro study on MDBK cell and BHV-1 virus
Z. Korvasová, L. Drašar, J. Mašek, P. Turánek Knotigová, P. Kulich, J. Matiašovic, K. Kovařčík, E. Bartheldyová, Š. Koudelka, M. Škrabalová, AD. Miller, A. Holý, M. Ledvina, J. Turánek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antivirové látky aplikace a dávkování farmakologie MeSH
- bovinní herpesvirus 1 účinky léků fyziologie MeSH
- buněčné kultury MeSH
- buněčné linie MeSH
- cytopatogenní efekt virový MeSH
- cytosin aplikace a dávkování analogy a deriváty farmakologie MeSH
- fluorescenční mikroskopie MeSH
- kationty MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- ledviny cytologie virologie MeSH
- lipidy chemie MeSH
- liposomy MeSH
- nosiče léků chemie MeSH
- organofosfonáty aplikace a dávkování farmakologie MeSH
- replikace viru účinky léků MeSH
- skot MeSH
- viabilita buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- skot MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We designed and synthesised a series of new cationic lipids based on spermine linked to various hydrophobic anchors. These lipids could be potentially useful for the preparation of stable cationic liposomes intended for the construction of drug targeting systems applicable in the field of anticancer/antiviral therapy, vaccine carriers, and vectors for the gene therapy. Low in vitro toxicity was found for these compounds, especially for LD1, in several cell lines. The delivery of both a fluorescence marker (calcein) and antiviral drugs into cells has been achieved owing to a large extent of internalization of cationic liposomes (labelled by Lyssamine-Rhodamine PE or fluorescein-PE) as demonstrated by fluorescent microscopy and quantified by flow cytometry. The bovine herpes virus type 1 (BHV-1) virus infection in vitro model using MDBK cells was employed to study the effect of the established antiviral drug HPMPC (Cidofovir®) developed by Prof. A. Holý. Inhibition of BHV-1 virus replication was studied by quantitative RT-PCR and confirmed by both Hoffman modulation contrast microscopy and transmission electron microscopy. We found that in vitro antiviral activity of HPMPC was significantly improved by formulation in cationic liposomes, which decreased the viral replication by about 2 orders of magnitude.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000950
- 003
- CZ-PrNML
- 005
- 20240827120039.0
- 007
- ta
- 008
- 130108s2012 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jconrel.2012.01.040 $2 doi
- 035 __
- $a (PubMed)22326403
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Korvasová, Zina $u Veterinary Research Institute, Department of Toxicology, Pharmacology and Immunotherapy, Brno, Czech Republic.
- 245 10
- $a Antiviral effect of HPMPC (Cidofovir®), entrapped in cationic liposomes: in vitro study on MDBK cell and BHV-1 virus / $c Z. Korvasová, L. Drašar, J. Mašek, P. Turánek Knotigová, P. Kulich, J. Matiašovic, K. Kovařčík, E. Bartheldyová, Š. Koudelka, M. Škrabalová, AD. Miller, A. Holý, M. Ledvina, J. Turánek,
- 520 9_
- $a We designed and synthesised a series of new cationic lipids based on spermine linked to various hydrophobic anchors. These lipids could be potentially useful for the preparation of stable cationic liposomes intended for the construction of drug targeting systems applicable in the field of anticancer/antiviral therapy, vaccine carriers, and vectors for the gene therapy. Low in vitro toxicity was found for these compounds, especially for LD1, in several cell lines. The delivery of both a fluorescence marker (calcein) and antiviral drugs into cells has been achieved owing to a large extent of internalization of cationic liposomes (labelled by Lyssamine-Rhodamine PE or fluorescein-PE) as demonstrated by fluorescent microscopy and quantified by flow cytometry. The bovine herpes virus type 1 (BHV-1) virus infection in vitro model using MDBK cells was employed to study the effect of the established antiviral drug HPMPC (Cidofovir®) developed by Prof. A. Holý. Inhibition of BHV-1 virus replication was studied by quantitative RT-PCR and confirmed by both Hoffman modulation contrast microscopy and transmission electron microscopy. We found that in vitro antiviral activity of HPMPC was significantly improved by formulation in cationic liposomes, which decreased the viral replication by about 2 orders of magnitude.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x aplikace a dávkování $x farmakologie $7 D000998
- 650 _2
- $a kationty $7 D002412
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a buněčné kultury $7 D018929
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a cytopatogenní efekt virový $7 D003588
- 650 _2
- $a cytosin $x aplikace a dávkování $x analogy a deriváty $x farmakologie $7 D003596
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a bovinní herpesvirus 1 $x účinky léků $x fyziologie $7 D007242
- 650 _2
- $a ledviny $x cytologie $x virologie $7 D007668
- 650 _2
- $a lipidy $x chemie $7 D008055
- 650 _2
- $a liposomy $7 D008081
- 650 _2
- $a fluorescenční mikroskopie $7 D008856
- 650 _2
- $a organofosfonáty $x aplikace a dávkování $x farmakologie $7 D063065
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a replikace viru $x účinky léků $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Drašar, Lukáš $7 xx0321479
- 700 1_
- $a Mašek, Josef
- 700 1_
- $a Turánek Knotigová, Pavlína
- 700 1_
- $a Kulich, Pavel
- 700 1_
- $a Matiašovic, Ján
- 700 1_
- $a Kovařčík, Kamil
- 700 1_
- $a Bartheldyová, Eliška
- 700 1_
- $a Koudelka, Štěpán
- 700 1_
- $a Škrabalová, Michaela
- 700 1_
- $a Miller, Andrew D
- 700 1_
- $a Holý, Antonín
- 700 1_
- $a Ledvina, Miroslav
- 700 1_
- $a Turánek, Jaroslav
- 773 0_
- $w MED00002621 $t Journal of controlled release $x 1873-4995 $g Roč. 160, č. 2 (2012), s. 330-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22326403 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20240827120035 $b ABA008
- 999 __
- $a ok $b bmc $g 963732 $s 799114
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 160 $c 2 $d 330-8 $i 1873-4995 $m Journal of controlled release $n J Controlled Release $x MED00002621
- LZP __
- $a Pubmed-20130108